Web22 dec. 2009 · The incidence of acute adverse reactions was significantly higher in the following groups: (1) iomeprol (3.9%) and iopromide (3.5%) groups, (2) patients aged 59 years or less (4.5%) compared with those aged 60 years or over (1.9%), (3) the first period (3.5%) compared with the late period (2.3%), (4) those with a past history of adverse … WebPurpose: To evaluate the nephrotoxicity of high- and low-osmolar contrast media (HOCM, LOCM) on kidneys in Sprague-Dawley rats. The protective role of amlodipine was studied. Material and Methods: Forty rats of both sexes were randomly divided into 5 groups (n = 8/group) and glycerine for inducing renal failure was given to all rats except controls.
Renal failure in 57925 patients undergoing ... - Kidney International
WebIohexol 300 at a concentration of 300 mgI/mL is indicated in adults for use in cerebral arteriography. Iohexol 300 is recommended for cerebral arteriography at the following … Web1 nov. 2010 · ObjectiveTo prospectively compare iopamidol 370, which is a low-osmolar contrast medium and iodixanol 320, which is an iso-osmolar contrast medium, in terms of image quality and nonserious adverse effects that have the potential to influence the image quality in a 16-slice multi-detector row computed tomography coronary angiography. piney woods arts and crafts
List of Non-ionic iodinated contrast media - Drugs.com
WebIn addition, iohexol can be administered intrathecally for use during myelography and to enhance myelographic computed tomography imaging. Iohexol was approved by the FDA on December 26, 1985. Iodinated contrast media can be classified as either ionic or nonionic and high-osmolar or low-osmolar. WebWe should mention, however, that multiple meta-analyses of randomized clinical trials have failed to demonstrate differences between IOCM and LOCM. 60,84 However, it has been pointed out that the relative renal safety of the low-osmolar iodixanol may vary with the different type of low-osmolar contrast agent, with a reduction in CI-AKI observed … WebThese agents include iohexol ( Omnipaque ), iopamidol (Isovue), ioversol (Optiray), and iopromide (Ultravist). Another approach to reducing osmolality was to develop dimeric molecules, essentially two tri-iodinated CM molecules joined together. piney woods baptist church